Skip to main content
Caplight Logo









Neuro

Neuro

Private
Las Vegas, NevadaConsumer & Commercehttps://neurogum.com/

Last Round

VC Round

Mar 11, 2026

Total Funding Raised

$8.27M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Neuro is a food products company that develops and sells functional chewing gum and mints infused with nootropics and vitamins to support energy, focus, calmness, and sleep.

Sector

Consumer & Commerce

Verticals

D2C Brands, Subscription Commerce, Sports & Fitness, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

functional gumnootropicsDTCcaffeinated mintsdirect-to-consumerenergy supplementcognitive supportfocus supplementcoffee alternativeportable energysmart drugssubscription commercebiohackingL-theaninestress management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuro Comparables

Compare Neuro with similar companies based on industry and business-model similarity.

Neuro comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Viter Energy
89%
REV GUM
86%
Dante Medical Solutions S.r.l.
84%

Neuro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 11, 2026
VC RoundOct 16, 2024
Series AFeb 8, 2023
CrowdfundingSep 1, 2015

Key People

Founding team and executive leadership

Ryan Chen

Co-Founder CFO

Founding Team

Kent Yoshimura

Co-Founder CEO

Founding Team

Neuro Investors

Notable investors and investment history

Neuro investors
InvestorRounds
PM Equity PartnerSeries A
BAM VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 4, 2026

    Grew 15% QoQ, from 244 to 281 employees.

  • Mar 11, 2026

    Funding round included participation from Daniel Lubetzky.

Neuro Filings

Explore SEC and related filing metadata, where available.

Neuro filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neuro's valuation, stock price, and market status.

Is Neuro a public or private company?

Neuro is a private company.

What is the current stock price of Neuro?

Neuro is a private company with no public stock price. No recent secondary market data is available.

How much is Neuro worth (valuation)?

Valuation information for Neuro is not publicly available.

Can I buy Neuro stock?

Neuro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neuro's last funding round?

Neuro's most recent funding round was VC Round on March 11, 2026.

Who are the main investors in Neuro?

Key investors in Neuro include PM Equity Partner, BAM Ventures.

Will Neuro IPO soon?

No public IPO plans have been announced for Neuro.

How can I track Neuro secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neuro's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLas Vegas, Nevada
Employee Range74
Year Founded2015
Last FundingMar 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?